LH-RH AGONIST, ZOLADEX (GOSERELIN), DEPOT FORMULATION IN THE TREATMENT OF PROSTATIC-CANCER - RANDOMIZED DOSE-FINDING TRIAL IN JAPAN

被引:8
作者
KOTAKE, T
USAMI, M
SONODA, T
MATSUDA, M
OKAJIMA, E
OSAFUNE, M
ISURUGI, K
AKAZA, H
SAITOH, Y
机构
[1] OSAKA UNIV,OSAKA,JAPAN
[2] NARA MED UNIV,KASHIHARA,NARA 634,JAPAN
[3] UNIV TOKYO,TOKYO 113,JAPAN
[4] NAGASAKI UNIV,NAGASAKI 852,JAPAN
[5] MINOO CITY HOSP,MINOO,JAPAN
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1988年 / 11卷
关键词
D O I
10.1097/00000421-198801102-00026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S108 / S111
页数:4
相关论文
共 4 条
[1]  
AHMED SR, 1983, LANCET, V2, P415
[2]  
FURR BJA, 1985, EORTC GENITOURINAR A, V2, P143
[3]  
WALKER KJ, 1983, LANCET, V2, P413
[4]   TREATMENT OF PATIENTS WITH ADVANCED CANCER OF THE PROSTATE USING A SLOW-RELEASE (DEPOT) FORMULATION OF THE LHRH AGONIST ICI-118630 (ZOLADEX) [J].
WALKER, KJ ;
TURKES, AO ;
TURKES, A ;
ZWINK, R ;
BEACOCK, C ;
BUCK, AC ;
PEELING, WB ;
GRIFFITHS, K .
JOURNAL OF ENDOCRINOLOGY, 1984, 103 (02) :R1-R4